Epigenetic Priming in Cancer Initiation
- 1 June 2018
- journal article
- review article
- Published by Elsevier in Trends in Cancer
- Vol. 4 (6) , 408-417
Abstract
No abstract availableKeywords
Funding Information
- European Commission
- Bundesministerium für Forschung, Technologie und Raumfahrt (PIE14/00066, SAF2012-32810, SAF2014-57791-REDC, SAF2015-64420-R)
- Federación Española de Enfermedades Raras (CP14/00082 – AES 2013–2016)
- Seventh Framework Programme
- Fundación Inocente, Inocente
- Fundación Ramón Areces
- Ministerio de Economía y Competitividad (SAF2017-83061)
- Instituto de Salud Carlos III (IBY15/00003, PI17/00167)
- Consejería de Educación, Junta de Castilla y León (BIO/SA51/15, CSI001U14, CSI001U16, UIC-017)
This publication has 81 references indexed in Scilit:
- A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitorsThe EMBO Journal, 2012
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid TransformationCancer Cell, 2011
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromesLeukemia, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The promises and perils of p53Nature, 2009
- Linking the p53 tumour suppressor pathway to somatic cell reprogrammingNature, 2009
- The Ink4/Arf locus is a barrier for iPS cell reprogrammingNature, 2009
- A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrityNature, 2009
- Cancer induction by restriction of oncogene expression to the stem cell compartmentThe EMBO Journal, 2008
- A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencingNature Genetics, 2007